COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?-An Insight from the GeroCovid Registry
THROMBOSIS AND HAEMOSTASIS(2022)
摘要
Introduction Atrial fibrillation (AF), the most frequent arrhythmia of older patients, associates with serious thromboembolic complications and high mortality. Coronavirus disease 2019 (COVID-19) severely affects aged subjects, determining an important prothrombotic status. The aim of this study was to evaluate mortality-related factors in older AF patients with COVID-19. Methods Between March and June 2020, we enrolled >= 60 year-old in-hospital COVID-19 patients ( n= 806) in GeroCovid, a multicenter observational study promoted by the Italian Society of Gerontology and Geriatric Medicine. Results The prevalence of AF was 21.8%. In-hospital mortality was higher in the AF group (36.9 vs. 27.5%, p =0.015). At admission, 51.7, 10.2, and 38.1% of AF cases were taking, respectively, oral anticoagulants (OACs), antiplatelet agents, and no antithrombotic therapy. During hospitalization, 51% patients switched to low-molecular-weight heparins. AF patients who survived were younger (818 vs. 84 +/- 7 years; p =0.002) and had a lower CHA (2) DS (2) -VASc score (3.9 +/- 1.6 vs. 4.4 +/- 1.3; p =0.02) than those who died. OAC use before (63.1 vs. 32.3%; p <0.001) and during hospitalization (34.0 vs. 12.7%; p =0.002) was higher among survivors. At multivariable analysis, lower age, higher self-sufficiency, less severe initial COVID-19 presentation, and the use of vitamin K antagonists (odds ratio [OR]=0.16, 95% confidence interval [CI]: 0.03-0.84) or direct OACs (OR=0.22, 95% CI: 0.08-0.56) at admission, or the persistence of OAC during hospitalization (OR=0.05, 95% CI: 0.01-0.24), were associated with a lower chance of in-hospital death. Conclusion AF is a prevalent and severe condition in older COVID-19 patients. Advanced age, dependency, and relevant clinical manifestations of disease characterized a worse prognosis. Preadmission and in-hospital anticoagulant therapies were positively associated with survival.
更多查看译文
关键词
atrial fibrillation, COVID-19, DOACs, aged, oral anticoagulants
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要